Imagion Biosystems Limited has given notice under section 708A(5)(e) of the Corporations Act 2001.
Read the notice.
Imagion MagSense Breast Cancer Program Phase 2 Clinical Trial Update
Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilising its proprietary MagSense® imaging